Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
401 The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: A single tertiary oncology center Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2020
402 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Rabab Mohammed Mamdouh Abdelhameed 2020
403 Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2020
404 Radiofrequency thoracic sympathectomy for sympathetically maintained chronic postmastectomy pain, a Preliminary Report:6 Month Results Department of Anesthesia, Intensive care and Pain management Prof. Ashraf Amin Mohamed 2020
405 Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial Department of Anesthesia, Intensive care and Pain management Dr. Rania Mohamed Abd-Elemam 2020
406 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
 		Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2020
407 Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study Department of Clinical Pathology Dr. Engy adel shafeek 2020
408 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2020
409 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2020
410 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2020